Filter posts

Fewer Small Public Biotechs Today

A lot can happen in six years. The number of active biotech companies currently trading …

Innovation Is… with Doug Doerfler of MaxCyte

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovation Is… with David Pyott of Allergan, Inc

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovation Is… with Stephan Tanda, Managing Board Member, Royal DSM

The term “innovation” is thrown around more often than Peyton Manning’s name during Fantasy Football …

Crowdfunding in Health Care and Biotechnology

Smaller private companies are constantly in search of capital, but many find it difficult to …

The New Road to IPO in the Age of the JOBS Act

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Have Questions About GMOs? We Know How to Get the Answers.

The ag biotech community – companies, scientists, health experts, farmers, industry organizations – have come …

What’s Really Happening with the So-called ‘Blend Wall’? A Fuels America Briefing

The public dialog surrounding the Renewable Fuel Standard is robust- and filled with misinformation. On …

Industry Growth Factor: Biologics

Last week, EvaluatePharma released their updated sales and R&D outlook for the drug industry in their …